1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Mycosis Fungoides Variant: new trials by email Literature Review of Mycosis Fungoides Variant trials Research Report on Mycosis Fungoides Variant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechlorethamine Induced Contact Dermatitis Avoidance Study Triamcinolone, Valchlor 0.016 % Topical Gel - Cutaneous T-cell Lymphoma, Cutaneous T-cell Lymphoma Stage I | Phase 2 | Completed | Rochester Skin Lymphoma Medical Group, PLLC | 28 | 2017-12-13 | 2026-09-04 |
Dermatitis, Contact (1) · Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1)
Dermatitis (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Skin Diseases (1) · Skin Diseases, Eczematous (1) · Skin and Connective Tissue Diseases (1)
Amines (1) · Gels (1) · Mechlorethamine (1) · Ointments (1) · Triamcinolone (1) · Triamcinolone Acetonide (1)
Rochester Skin Lymphoma Medical Group, PLLC (1)
United States (1)